Stay updated on ASG-22CE Dose Escalation in Nectin-4+ Tumors Clinical Trial

Sign up to get notified when there's something new on the ASG-22CE Dose Escalation in Nectin-4+ Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ASG-22CE Dose Escalation in Nectin-4+ Tumors Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Footer shows Revision: v3.3.2, replacing v3.3.1; no study content or functionality was changed.
    Difference
    0.0%
    Check dated 2025-12-01T17:42:53.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.1; no substantive changes to study details or page layout were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T14:48:23.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The government funding status notice/banner was removed from the page, removing the instruction to check opm.gov for updates.
    Difference
    0.3%
    Check dated 2025-11-17T06:55:26.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    This page update appears limited to administrative details (e.g., last update date) and minor formatting changes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:18:05.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    - Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.
    Difference
    2%
    Check dated 2025-10-05T10:17:36.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Incremental version update: from v3.0.2 to v3.1.0 in the Revision header. No other substantive content changes indicated.
    Difference
    0.1%
    Check dated 2025-09-28T03:15:33.000Z thumbnail image

Stay in the know with updates to ASG-22CE Dose Escalation in Nectin-4+ Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ASG-22CE Dose Escalation in Nectin-4+ Tumors Clinical Trial page.